TSN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tyson Foods Inc (TSN) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive catalysts, the financial performance and mixed analyst ratings suggest a cautious approach. Holding the stock or waiting for further clarity on financial improvements may be a better option.
The technical indicators show a bullish trend with MACD positively expanding, RSI neutral at 75.543, and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at R1: 64.295 and R2: 65.911, while support levels are at S1: 59.062 and S2: 57.446. However, the stock's short-term trend suggests a slight decline in the next day and week, with a potential 2.23% gain over the next month.
Hedge funds are significantly increasing their buying activity, with a 47960.00% increase over the last quarter.
Mizuho and BMO Capital have positive outlooks on the stock, citing structural growth in protein demand and operational improvements.
The stock has a diversified operating model, which is favorable in challenging beef market conditions.
Financial performance in Q1 2026 shows significant declines in net income (-76.32% YoY), EPS (-76.24% YoY), and gross margin (-14.14% YoY), despite a 6.17% YoY increase in revenue.
Mixed analyst ratings, with some firms maintaining Neutral or Sell ratings and price targets as low as $
No recent news or congress trading data to provide additional positive sentiment.
In Q1 2026, Tyson Foods reported revenue growth of 6.17% YoY to $14.46 billion. However, net income dropped significantly by 76.32% YoY to $85 million, and EPS fell by 76.24% YoY to $0.24. Gross margin also declined to 7.35%, down 14.14% YoY, indicating challenges in profitability despite revenue growth.
Analyst ratings are mixed. Positive ratings include Mizuho's Outperform with a $72 price target and BMO's Outperform with a $73 price target, citing operational improvements and favorable industry dynamics. However, JPMorgan, BofA, and Bernstein maintain Neutral ratings with price targets ranging from $65 to $69, while BTG Pactual has a Sell rating with a $58 price target. The consensus reflects cautious optimism but highlights challenges in the beef segment.
